Speciality Medicines Ltd vs Vivo Bio Tech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Speciality Medicines Ltd is ₹ 203 as of 12 Jun 15:30 . The P/E Ratio of Speciality Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vivo Bio Tech Ltd changed from 11.3 on March 2021 to 8 on March 2025 . This represents a CAGR of -6.67% over 5 years The Market Cap of Speciality Medicines Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vivo Bio Tech Ltd changed from ₹ 64.28 crore on March 2021 to ₹ 57.3 crore on March 2025 . This represents a CAGR of -2.27% over 5 years The revenue of Speciality Medicines Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vivo Bio Tech Ltd for the Mar '26 is ₹ 14.23 crore as compare to the Dec '25 revenue of ₹ 13.65 crore. This represent the growth of 4.25% The ebitda of Speciality Medicines Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vivo Bio Tech Ltd for the Mar '26 is ₹ 4.48 crore as compare to the Dec '25 ebitda of ₹ 5.63 crore. This represent the decline of -20.43% The net profit of Speciality Medicines Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Vivo Bio Tech Ltd changed from ₹ 0.17 crore to ₹ -5.16 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Speciality Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vivo Bio Tech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Speciality Medicines Ltd

Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre.
Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market.
The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet.

About Vivo Bio Tech Ltd

Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines.
The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies, Genotoxicity screening, Analytical services etc.
Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. The Company stands as a premier and primary provider of SPF lab animals in India.
It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences.

FAQs for the comparison of Speciality Medicines Ltd and Vivo Bio Tech Ltd

Which company has a larger market capitalization, Speciality Medicines Ltd or Vivo Bio Tech Ltd?

Market cap of Speciality Medicines Ltd is 178 Cr while Market cap of Vivo Bio Tech Ltd is 52 Cr

What are the key factors driving the stock performance of Speciality Medicines Ltd and Vivo Bio Tech Ltd?

The stock performance of Speciality Medicines Ltd and Vivo Bio Tech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Speciality Medicines Ltd and Vivo Bio Tech Ltd?

As of June 15, 2026, the Speciality Medicines Ltd stock price is INR ₹203.0. On the other hand, Vivo Bio Tech Ltd stock price is INR ₹23.77.

How do dividend payouts of Speciality Medicines Ltd and Vivo Bio Tech Ltd compare?

To compare the dividend payouts of Speciality Medicines Ltd and Vivo Bio Tech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.